Story thread · 2 reports / 1 sources
Merck reports positive phase 2 trial results for HS treatment
investing.com · 3h
First report: MediciNova reports mixed phase 2 results for MN-001 drug trial — investing.com, 2d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.